16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
13
Inhibiting the deubiquitinating enzymes (DUBs).

Genentech
14
Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies.

Zhengzhou University
2
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

University of Cambridge
17
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives.

University of Bologna
6
Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer.

Fudan University
15
Discovery of USP7 small-molecule allosteric inhibitors.

Medivir
50
Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy.

Mitobridge, Inc. (An Astellas)
36
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity.

Rapt Therapeutics
1
Salt of LSD1 inhibitor and a polymorph thereof

Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)
92
DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES

Ucb Biopharma
6
5-aminolevulinate synthase inhibitors and methods of use thereof

University of South Florida
12
Substituted nucleosides, nucleotides and analogs thereof

Janssen Biopharma
117
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

Vanderbilt University
55
1,3,4-thiadiazole compounds and their use in treating cancer

AstraZeneca
47
Thiazole derivatives

Merck Patent
26
Design and Synthesis of Classical and Nonclassical 6-Arylthio-2,4-diamino-5-ethylpyrrolo[2,3-d]pyrimidines as Antifolates.

Duquesne University